Nurse Practitioner · Grand Rapids, MI
NPI
1124184460
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3210 Eagle Run Dr NE
Grand Rapids, MI, 49525
Phone (616) 456-9553
Groups this clinician bills Medicare through
Medicare paid, 2023
$1,953
28 services
Medicare patients, 2023
24
Average age 75
Drug cost, 2024
$2.4M
12,993 prescriptions
Company payments, 2025
$1,921
From 24 companies
Procedures and visits billed to Original Medicare, 2023
In 2023, the most common Medicare service billed by Lindsay R Gibbons was code 99214 (office e&m - established), 14 times for 14 patients. In total Lindsay R Gibbons billed 28 services in 9 codes, and Medicare paid $1,953.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 14 | 14 | $81.39 | $1,139 |
By year: 2022 $3,491 for 70 services; 2023 $1,953 for 28 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lindsay R Gibbons prescribed most often to Medicare patients was Metoprolol Succinate, with 1,495 prescriptions and refills. In total Lindsay R Gibbons wrote 12,993 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,495 | 4,041 | 612 | $37K |
| Atorvastatin Calcium Generic | 1,023 | 2,867 | 402 | $19K |
| Rosuvastatin Calcium Generic | 820 | 2,351 | 338 | $19K |
| Losartan Potassium Generic | 758 | 2,146 | 317 | $13K |
| Furosemide Generic | 753 | 1,873 | 300 | $5,655 |
| Amlodipine Besylate Generic | 749 | 2,082 | 301 | $6,711 |
| Eliquis Apixaban | 709 | 1,511 | 242 | $818K |
| Clopidogrel Clopidogrel Bisulfate | 644 | 1,753 | 260 | $13K |
| Ezetimibe Generic | 546 | 1,528 | 217 | $15K |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 432 | 1,159 | 178 | $8,297 |
| Lisinopril Generic | 385 | 1,048 | 148 | $4,320 |
| Entresto Sacubitril/Valsartan | 310 | 648 | 111 | $400K |
| Carvedilol Generic | 307 | 866 | 139 | $4,668 |
| Potassium Chloride Generic | 279 | 720 | 127 | $7,530 |
| Metoprolol Tartrate Generic | 235 | 696 | 105 | $2,847 |
Brand drugs: 1,919 claims; generic drugs: 11,074 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lindsay R Gibbons $1,921 ($1,921 in general payments such as food, travel and fees) from 24 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $402.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 28 | $402 |
| Novo Nordisk Inc NVO | 11 | $221 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $217 |
| Amgen Inc. AMGN | 13 | $215 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $93.92 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $81.41 |
| Pfizer Inc. PFE | 4 | $79.48 |
| Lilly USA, LLC LLY | 4 | $70.26 |
| Merck Sharp & Dohme LLC MRK | 3 | $65.81 |
| Daiichi Sankyo Inc. 4568.T | 3 | $63.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.